Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Research and Development Expense (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 82.95M
March 31, 2026 80.74M
December 31, 2025 75.00M
September 30, 2025 70.74M
June 30, 2025 75.22M
March 31, 2025 80.06M
December 31, 2024 85.03M
September 30, 2024 95.20M
June 30, 2024 90.26M
March 31, 2024 88.92M
December 31, 2023 87.67M
September 30, 2023 83.58M
June 30, 2023 88.39M
March 31, 2023 91.64M
December 31, 2022 97.09M
September 30, 2022 108.03M
June 30, 2022 118.65M
March 31, 2022 124.37M
December 31, 2021 128.84M
September 30, 2021 119.83M
June 30, 2021 105.61M
March 31, 2021 97.32M
Date Value
December 31, 2020 87.04M
September 30, 2020 94.01M
June 30, 2020 95.51M
March 31, 2020 98.07M
December 31, 2019 91.85M
September 30, 2019 82.79M
June 30, 2019 79.89M
March 31, 2019 72.51M
December 31, 2018 76.40M
September 30, 2018 75.84M
June 30, 2018 78.71M
March 31, 2018 79.27M
December 31, 2017 81.75M
September 30, 2017 81.17M
June 30, 2017 76.83M
March 31, 2017 80.27M
December 31, 2016 80.21M
September 30, 2016 77.63M
June 30, 2016 75.38M
March 31, 2016 65.02M
December 31, 2015 50.51M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
DBV Technologies SA 117.13M
Akari Therapeutics Plc 4.869M
EDAP TMS SA --
Autolus Therapeutics Plc 112.42M
Evaxion AS 10.27M